Aripiprazole
Generic Name: aripiprazole
Brand Names:
Aripiprazole
Aripiprazole is an atypical antipsychotic medication available as orally disintegrating tablets.
Overview
Aripiprazole is an atypical antipsychotic medication available as orally disintegrating tablets.
Uses
Indicated for treatment of schizophrenia in adults and adolescents (13-17 years), irritability associated with autistic disorder in children and adolescents (6-17 years), and Tourette's disorder.
Dosage
For schizophrenia in adults: initial dose 10-15 mg/day, recommended 10-15 mg/day, maximum 30 mg/day. For adolescents (13-17 years): initial 2 mg/day, target 10 mg/day, maximum 30 mg/day. For autistic disorder (6-17 years): initial 2 mg/day, target 5-10 mg/day, maximum 15 mg/day.
Side Effects
Common adverse reactions in adults include nausea, vomiting, constipation, headache, dizziness, akathisia, anxiety, insomnia, and restlessness. In pediatric patients: somnolence, headache, vomiting, extrapyramidal disorder, fatigue, increased appetite, insomnia, nausea, and weight increase.
Warnings
Elderly patients with dementia-related psychosis treated with antipsychotic drugs face increased risk of death. Aripiprazole is not approved for dementia-related psychosis. Increased risk of suicidal thinking in children, adolescents, and young adults. Monitor closely for worsening and emergence of suicidal thoughts.
Frequently Asked Questions
What is Aripiprazole used for?▼
Indicated for treatment of schizophrenia in adults and adolescents (13-17 years), irritability associated with autistic disorder in children and adolescents (6-17 years), and Tourette's disorder.
What are the side effects of Aripiprazole?▼
Common adverse reactions in adults include nausea, vomiting, constipation, headache, dizziness, akathisia, anxiety, insomnia, and restlessness. In pediatric patients: somnolence, headache, vomiting, extrapyramidal disorder, fatigue, increased appetite, insomnia, nausea, and weight increase.
What are the important warnings for Aripiprazole?▼
Elderly patients with dementia-related psychosis treated with antipsychotic drugs face increased risk of death. Aripiprazole is not approved for dementia-related psychosis. Increased risk of suicidal thinking in children, adolescents, and young adults. Monitor closely for worsening and emergence of suicidal thoughts.
Related Medications
Oxaprozin Potassium
oxaprozin potassium
Manufactured by PFIZER. Dosage form: TABLET. Route: ORAL. Active ingredients: OXAPROZIN POTASSIUM (600MG). Application: NDA020776.
Posaconazole (form- 1)
posaconazole (form- 1)
Dosage form: POWDER. Active ingredients: POSACONAZOLE (1 kg/kg). Category: BULK INGREDIENT.
Hepatitis A And Hepatitis B (recombinant) Vaccine
hepatitis a and hepatitis b (recombinant) vaccine
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) (720 [iU]/mL); HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN (20 ug/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.